FDAnews Drug Daily Bulletin

MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I

March 16, 2010
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, Monday announced that it has filed an Investigational New Drug application with the State Food and Drug Administration in China for MRX-I, its first development-stage antibiotic drug candidate.
Fox Business